FDA — authorised 28 December 2022
- Application: BLA761192
- Marketing authorisation holder: MEDIWOUND, LTD
- Local brand name: NEXOBRID
- Indication: GEL — TOPICAL
- Status: approved
🇺🇸 Nexobrid in United States
FDA authorised Nexobrid on 28 December 2022
Marketing authorisation
Nexobrid in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Nexobrid approved in United States?
Yes. FDA authorised it on 28 December 2022.
Who is the marketing authorisation holder for Nexobrid in United States?
MEDIWOUND, LTD holds the US marketing authorisation.